logo

For the Inventor, By the Inventor

Cherry Hill, NJ, United States of America

Jaspal S Khillan

This inventor holds 5 USPTO granted patents. Top assignee: Thomas Jefferson University. Active years: 1995-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaspal S Khillan. Retrieved from https://idiyas.com/inventor/jaspal-s-khillan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 58(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1997)
  • Cherry Hill, NJ (US) (1995 - 2002)

Company Filing History:

goldMedal5 out of 538 
 
Thomas Jefferson University
 patents

Years Active: 1995-2002

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6448470 - Transgenic COL2A1-null mice expressing human COL2A1 (2002-09-10),
2. 6281408 - Efficient method for production of compound transgenic animals (2001-08-28),
3. 5786341 - Use of a COL1A1 mini-gene construct to inhibit collagen synthesis (1998-07-28),
4. 5663482 - Transgenic mice expressing a mutated human collagen gene (1997-09-02),
5. 5449620 - Apparatus and method for culturing embryonic stem cells (1995-09-12),

Title: Jaspal S Khillan: Innovator in Transgenic Research

Introduction

Jaspal S Khillan is a prominent inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of transgenic research, particularly in the development of animal models for studying cartilage-related disorders. With a total of 5 patents, his work has paved the way for advancements in therapeutic approaches.

Latest Patents

Among his latest patents, Khillan has developed transgenic COL2A1-null mice expressing human COL2A1. This innovation involves transgenic animals that express a human collagen gene while having an inactivated endogenous collagen gene. Additionally, he has provided compositions comprising humanized chondrocytes isolated from these transgenic animals. His work also includes methods for screening potential therapeutics for cartilage-related disorders using these animals. Another notable patent is an efficient method for the production of compound transgenic animals, which involves co-culturing embryonic stem cells with a morula.

Career Highlights

Jaspal S Khillan is affiliated with Thomas Jefferson University, where he continues to advance his research in transgenic technologies. His work has garnered attention for its potential applications in regenerative medicine and therapeutic development.

Collaborations

Khillan has collaborated with esteemed colleagues, including Darwin J Prockop and Shi-Wu Li, to further enhance the impact of his research in the scientific community.

Conclusion

Jaspal S Khillan's innovative contributions to transgenic research highlight his role as a leading inventor in the field. His patents and ongoing work continue to influence the development of new therapeutic strategies for cartilage-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…